Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study
Andrea Lazzarotto(Centre National de la Recherche Scientifique), Benedetta Bodini(Inserm), Nicola De Stefano(University of Siena), Raffaele Palladino, Émilie Poirion(Inserm), Bruno Stankoff(Pitié-Salpêtrière Hospital), Mattéo Tonietto(Centre National de la Recherche Scientifique), Marco Battaglini(University of Siena), Vito A. G. Ricigliano(Inserm), Élisabeth Maillart(Sorbonne Université), Charline Benoit(Commissariat à l'Énergie Atomique et aux Énergies Alternatives)
Cited by 13
Related Papers
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
|Brain|2019|554
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
|The Lancet Neurology|2015|523
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518